EXELLENS Trademark
Trademark Overview
On Wednesday, October 1, 2025, a trademark application was filed for EXELLENS with the United States Patent and Trademark Office. The USPTO has given the EXELLENS trademark a serial number of 99422777. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Monday, June 8, 2026. This trademark is owned by Samsung Biologics Co., Ltd.. The EXELLENS trademark is filed in the Advertising, Business and Retail Services, Treatment & Processing of Materials Services, and Computer & Software Services & Scientific Services categories with the following description:
business administration and office work; marketing services; demonstration of goods; import-export agency services; advertising services relating to pharmaceutical products; business advisory services for business in the field of medical services and healthcare; electronic data collection services for business purposes in the pharmaceutical and healthcare fields; providing consumer product information via the Internet; electronic data processing services relating to healthcare information; accounting consultancy services; healthcare cost management services; statistical analysis for research, development, and manufacturing in the field of biopharmaceuticals; data evaluation, and preparation of business reports in the field of biopharmaceutical research
conducting early evaluations in the field of new pharmaceuticals; drug discovery services; pharmaceutical research and development; research of pharmaceuticals; pharmaceutical product evaluation; scientific services, namely, toxicity analysis, cell-based toxicity assays, in vitro toxicity testing, bio-safety testing during drug development and manufacturing; scientific research services in the field of conducting clinical trials and supports for others; clinical studies of medicines; services for assessing the efficiency of pharmaceuticals, namely, potency and efficacy testing; analysis and evaluation of medical product development; medical research laboratory services; providing information on the testing, inspection and research of medical products; medicine research; evaluating of clinical trial progress being target group setting and data collection for scientific research purposes; computer programming services in the medical field; multiple nucleic acid analysis; scientific servi...
Custom manufacture of biopharmaceuticals, processing of medicinal materials; preservation of pharmaceuticals; processing of pharmaceuticals; processing of chemicals; processing of biopharmaceutical materials for others; processing of biopharmaceutical products, namely, raw materials, cell culture, purification, and formulation services; chemical treatment of liquids; custom manufacturing of cell lines for biopharmaceutical production; custom manufacturing of glycosylated pharmaceutical preparations with specific antibody binding
General Information
| Serial Number | 99422777 |
| Word Mark | EXELLENS |
| Filing Date | Wednesday, October 1, 2025 |
| Status | 653 - SUSPENSION LETTER - MAILED |
| Status Date | Monday, June 8, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | business administration and office work; marketing services; demonstration of goods; import-export agency services; advertising services relating to pharmaceutical products; business advisory services for business in the field of medical services and healthcare; electronic data collection services for business purposes in the pharmaceutical and healthcare fields; providing consumer product information via the Internet; electronic data processing services relating to healthcare information; accounting consultancy services; healthcare cost management services; statistical analysis for research, development, and manufacturing in the field of biopharmaceuticals; data evaluation, and preparation of business reports in the field of biopharmaceutical research |
| Goods and Services | conducting early evaluations in the field of new pharmaceuticals; drug discovery services; pharmaceutical research and development; research of pharmaceuticals; pharmaceutical product evaluation; scientific services, namely, toxicity analysis, cell-based toxicity assays, in vitro toxicity testing, bio-safety testing during drug development and manufacturing; scientific research services in the field of conducting clinical trials and supports for others; clinical studies of medicines; services for assessing the efficiency of pharmaceuticals, namely, potency and efficacy testing; analysis and evaluation of medical product development; medical research laboratory services; providing information on the testing, inspection and research of medical products; medicine research; evaluating of clinical trial progress being target group setting and data collection for scientific research purposes; computer programming services in the medical field; multiple nucleic acid analysis; scientific services being protein analysis for IPC, namely, release, stability testing, compendial testing, protein concentration, chemical/biochemical testing, protein characterization, and quantification; biotechnological research; genetic research, namely, gene expression analysis; scientific research; scientific molecular analysis services, namely, DNA and RNA analysis; research in the field of food; development in the field of biotechnology; biochemical analysis services; scientific research in the field of genetics and genetic engineering; biochemical research; cell culture services for scientific research purposes for others; biological analysis, namely, IPC (In-Process Control), release, and stability testing such as cell-based assays and binding ELISA (Enzyme-Linked Immunosorbent Assay), and biomarker analysis of biological samples; biological research; research of biologics; development of pharmaceutical preparations and medicines; scientific laboratory services for high-throughput glycan analysis; biological research and analysis relating to glycosylation profiling; technical support services for computer software in the nature of development and manufacturing process optimization/simulation, trend analysis, and risk management relating to handling of medical imaging data |
| Goods and Services | Custom manufacture of biopharmaceuticals, processing of medicinal materials; preservation of pharmaceuticals; processing of pharmaceuticals; processing of chemicals; processing of biopharmaceutical materials for others; processing of biopharmaceutical products, namely, raw materials, cell culture, purification, and formulation services; chemical treatment of liquids; custom manufacturing of cell lines for biopharmaceutical production; custom manufacturing of glycosylated pharmaceutical preparations with specific antibody binding |
Classification Information
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, October 1, 2025 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, October 1, 2025 |
| Primary Code | 040 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, October 1, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Samsung Biologics Co., Ltd. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Incheon 21987
KR |
Trademark Events
| Event Date | Event Description |
| Wednesday, October 1, 2025 | NEW APPLICATION ENTERED |
| Wednesday, October 1, 2025 | APPLICATION FILING RECEIPT MAILED |
| Tuesday, February 10, 2026 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, February 20, 2026 | ASSIGNED TO EXAMINER |
| Saturday, February 21, 2026 | NON-FINAL ACTION WRITTEN |
| Saturday, February 21, 2026 | NON-FINAL ACTION E-MAILED |
| Saturday, February 21, 2026 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, May 12, 2026 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, May 12, 2026 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, May 12, 2026 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, June 8, 2026 | SUSPENSION LETTER WRITTEN |
| Monday, June 8, 2026 | LETTER OF SUSPENSION E-MAILED |
| Monday, June 8, 2026 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
